Otezla 30 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FFL9N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,298
Award facts
- Contract value 100% obligated
- $38,298.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $38,298.09 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 30, 2026, for the supply of Otezla 30 mg tablets (60-count units). This non-set-aside competitive award is scheduled for completion by February 2, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor within the federal medical procurement system, leveraging its substantial IDC to fulfill diverse medical supply requirements across military treatment facilities and other government healthcare entities. As a major distributor of both brand-name and generic medications, the company maintains the capability to supply an extensive range of pharmaceutical commodities, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Otezla, a prescription medication used primarily for psoriatic arthritis and plaque psoriasis treatment, exemplifies the company's role in supporting military and federal healthcare systems through competitive, firm fixed-price transactions under its master contract vehicle.
Quick answers
Who was awarded contract SPE2DR26FFL9N?
SPE2DR26FFL9N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FFL9N worth?
The government has obligated $38,298 on SPE2DR26FFL9N.
Is contract SPE2DR26FFL9N an order under another contract?
Yes. SPE2DR26FFL9N is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL9N competed?
The extent of competition for SPE2DR26FFL9N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award